InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,745.37
(
0.40%
)
US TECH 100
19,595.20
(
0.84%
)
Dow Jones
42,175.11
(
0.62%
)
Brent Oil
70.95
(
-3.06%
)
Bitcoin
64,957.78
(
2.89%
)
Post# of 253240
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120506
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 221746

Tuesday, 10/30/2018 10:00:43 AM

Tuesday, October 30, 2018 10:00:43 AM

Post# of 253240
(RVNC)—3Q18 worldwide Botox sales=$879.7M, +14% YoY (-6% QoQ*):

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNzU1Mjd8Q2hpbGRJRD03MDEwNzI=

• US therapeutic: $407.4M (+10 YoY)
• US cosmetic: $216.0M (+14% YoY)
• Ex-US therapeutic: $92.9 (+17 YoY in constant currency)
• Ex-US cosmetic: $163.4M (+33% YoY in constant currency)

All told, 71% of Botox sales were in the US, where the therapeutic/cosmetic split was 65/35; 29% of Botox sales were ex-US, where the therapeutic/cosmetic split was 36/64.

*The 3Q18 decline relative to 2Q18 was expected; Botox is seasonally stronger in the second and fourth quarters of the calendar year.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up